REQUEST A DEMO
Total
USD $0.00
Search more companies

Mycenax Biotech Inc. (永昕生物医药股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Mycenax Biotech Inc. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Mycenax Biotech Inc. (永昕生物医药股份有限公司) is an enterprise in Taiwan, China, with the main office in Hsinchu City. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. Mycenax Biotech Inc. (永昕生物医药股份有限公司) was incorporated on September 28, 2001. It currently has a total number of 378 (2023) employees. There was a net sales revenue drop of 7% reported in Mycenax Biotech Inc. (永昕生物医药股份有限公司)’s latest financial highlights for Q3C2025. During that time, Mycenax Biotech Inc. (永昕生物医药股份有限公司)’s total assets decreased by 4.28%. In 2025, Mycenax Biotech Inc. (永昕生物医药股份有限公司)’s net profit margin decreased by 8.6%.

Headquarters
7F., No. 66, Shengyi 2Nd Rd Zhubei City
Hsinchu City; Hsinchu City;

Contact Details: Purchase the Mycenax Biotech Inc. (永昕生物医药股份有限公司) report to view the information.

Website: http://www.mycenax.com

Basic Information
Total Employees:
Purchase the Mycenax Biotech Inc. (永昕生物医药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Mycenax Biotech Inc. (永昕生物医药股份有限公司) report to view the information.
Financial Auditors:
Purchase the Mycenax Biotech Inc. (永昕生物医药股份有限公司) report to view the information.
Incorporation Date:
September 28, 2001
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
19.9%
Purchase this report to view the information.
1.99%
Purchase this report to view the information.
1.24%
Purchase this report to view the information.
0.8%
Purchase this report to view the information.
0.75%
Subsidiaries
Mycenax Biotech Usa, Llc (United States)
100%
Company Performance
Financial values in the chart are available after Mycenax Biotech Inc. (永昕生物医药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-7%
Total Operating Revenue
-8.16%
Operating Profit
3.3%
EBITDA
-2.18%
Net Profit/Loss for the Period
-3.21%
Total Assets
-4.28%
Total Equity
-21.66%
Operating Profit Margin
-2.99%
Net Profit Margin
-8.6%
Return on Equity (ROE)
-5.81%
Debt / Equity
24486%
Quick Ratio
-520.08%
Cash Ratio
-0.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?